Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Curie-Cancer and Strand Launch Curie Image Database

Published: Wednesday, December 18, 2013
Last Updated: Wednesday, December 18, 2013
Bookmark and Share
A breakthrough image management platform for scientists.

Curie-Cancer and Strand Scientific Intelligence, Inc. (Strand) have announced the launch of the Curie Image Database (CID), a breakthrough image analysis and management platform that they developed jointly over the last two years at the Cell and Tissue Imaging Core Facility of the Institut Curie (PICT-IBiSA).

CID was created using Strand’s award-winning Avadis® platform. It now enables over 250 scientists at Institut Curie and ten other collaborating institutions across Europe to effectively manage heterogeneous imaging data and complex analysis workflows.

CID (or Avadis® iMANAGE outside the Institut Curie network) provides shared, secure and open access to image life cycle data as well as image analysis algorithms.

“Institut Curie’s expertise in advanced imaging platforms and Strand's ability to engineer superior scientific software have come together to create a scalable, secure and efficient ’open access‘ platform for microscopy images and analysis algorithms,” says Professor Vijay Chandru, co-founder and CEO of Strand. “We are excited by the launch of this platform at the world’s leading cancer research institute. Strand has built an advanced genome sequencing-based diagnostic platform for oncology. Going forward we would like to explore with Institut Curie an advanced decision support platform for oncologists that integrates genomic signatures of cancers and imaging data towards better diagnosis and treatment of cancer patients.”

“Our goal was not only to provide an image ‘management’ system but also an interactive research tool that allows data and analysis sharing for distant and multidisciplinary projects between teams from different labs and institutes that is able to handle the exponential growth and complexity of scientific and biomedical images generated by advanced microscopy systems,” says Jean Salamero, scientific director of Cell and Tissue Imaging Core Facility at Curie-Cancer.

“Funding through the France Bio-Imaging program and Canceropole-IdF, a French network of institutions dedicated to oncology, allowed us to link CID to a new and secure storage infrastructure and to promote access to image processing on dedicated clusters. Going forward, we would like to integrate this image database with other types of data, like genomic data or clinical and anatomy-pathological data related to clinical projects, resulting in an even more effective weapon in our fight against cancer.”

“Such a partnership project may ultimately help with the treatment of cancer. We are delighted to have contributed to the implementation of this technology developed by an international SME like Strand, whose roots are in India,” says Damien Salauze, director of Curie-Cancer. “This partnership embodies the principles of the Institut Carnot label which we were awarded by the French government in 2011 in recognition of our drive to provide genuine solutions for industry and ultimately for patients.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Curie-Cancer and Meiogenix Sign Two Partnership Agreements
Curie-Cancer and Meiogenix will develop the SpiX technology in yeast and in mice to unlock unexplored genetic diversity.
Tuesday, November 19, 2013
Curie-Cancer Trebles Early Phase Clinical Research Studies with Industry Partners
Ten early stage clinical studies (phase I) were conducted in 2012, trebling since 2010 and continuing to grow in 2013.
Tuesday, March 26, 2013
Curie-Cancer and Harmonic Pharma Sign a Partnership Agreement
Under this multi-year research collaboration, Curie-Cancer will give Harmonic Pharma access to its extensive collection of patient-derived xenografts representative of human tumors.
Tuesday, November 06, 2012
Scientific News
One Giant Leap for the Future of Safe Drug Delivery
Sheffield engineers make major breakthrough in developing silk ‘micro-rockets’ that can be used safely in biological environments.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Fix for 3-Billion-Year-Old Genetic Error
Researchers at The University of Texas at Austin have developed a fix that allows RNA to accurately proofread for the first time.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!